Published in Environ Res on June 01, 1978
Ozone and pulmonary innate immunity. Proc Am Thorac Soc (2007) 1.61
Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences. Respir Res (2008) 1.00
Ozone killing action against bacterial and fungal species; microbiological testing of a domestic ozone generator. J Clin Pathol (1983) 0.98
Ambient ozone and pulmonary innate immunity. Immunol Res (2011) 0.93
The effects of ozone on immune function. Environ Health Perspect (1995) 0.88
Early life ozone exposure results in dysregulated innate immune function and altered microRNA expression in airway epithelium. PLoS One (2014) 0.78
Genes of innate immunity and the biological response to inhaled ozone. J Biochem Mol Toxicol (2012) 0.78
The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell (1996) 4.93
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation (1998) 2.28
Regulated production of mu m and mu s mRNA requires linkage of the poly(A) addition sites and is dependent on the length of the mu s-mu m intron. Proc Natl Acad Sci U S A (1986) 2.19
Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother (2000) 1.65
Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels. Nucleic Acids Res (1997) 1.55
Feasibility of an Extended MPH Degree Program for fully employed practicing health professionals. Am J Public Health (1984) 1.47
Effect of Soil-Moisture Content on the Rate of Photosynthesis and Respiration in Ladino Clover (Trifolium Repens L.). Plant Physiol (1955) 1.38
Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis (1989) 1.26
Dry-heat resistance of bacterial spores recovered from mariner-Mars 1969 spacecraft. Appl Microbiol (1971) 1.25
Anatomy and actions of the trapezius muscle. Clin Biomech (Bristol, Avon) (1994) 1.19
Properties of lac P2 in vivo and in vitro. An overlapping RNA polymerase binding site within the lactose promoter. J Mol Biol (1985) 1.17
The relation between initial symptoms and signs and the prognosis of whiplash. Eur Spine J (2001) 1.17
Behavioral demonstration of a somatosensory neuroprosthesis. IEEE Trans Neural Syst Rehabil Eng (2013) 1.12
Clinical pharmacokinetics of sevoflurane. Clin Pharmacokinet (1999) 1.12
Interspecialty variation in office-based care. Med Care (1984) 1.10
Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone. Am J Respir Crit Care Med (1994) 1.08
Comparison of Southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33, and 35. Am J Clin Pathol (1990) 1.08
Lactose promoter mutation Pr115 activates an overlapping promoter within the lactose control region. J Mol Biol (1985) 1.05
A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer (2000) 1.02
A nonimmunoglobulin transgene and the endogenous immunoglobulin mu gene are coordinately regulated by alternative RNA processing during B-cell maturation. Mol Cell Biol (1998) 1.00
Structure and activities of hospital drug committees in Germany. Eur J Clin Pharmacol (1997) 0.99
Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells. Transplant Proc (1999) 0.99
Scale-up of adhesive transdermal drug delivery systems. Pharm Res (1997) 0.98
Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes. Drug Metab Dispos (1991) 0.98
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int (2001) 0.98
Drug utilization review on a surgical intensive care unit. Int J Clin Pharmacol Ther (1994) 0.98
Visual contrast sensitivity deficits in Bohemian children. Neurotoxicology (1997) 0.98
Neutrophil influx measured in nasal lavages of humans exposed to ozone. Arch Environ Health (1988) 0.97
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid. Int J Clin Pharmacol Ther Toxicol (1989) 0.97
The Institute of Medicine report, "A Manpower Policy for Primary Health Care": a commentary from the American College of Physicians. Ann Intern Med (1980) 0.96
Soiled disposable diapers: a potential source of viruses. Am J Public Health (1974) 0.94
Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology (2003) 0.92
In vitro analysis of verapamil-induced immunosuppression: potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells. Transplantation (2000) 0.91
Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur J Clin Pharmacol (1986) 0.90
Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth (2011) 0.90
The place of the general internist in primary care. Ann Intern Med (1979) 0.89
Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? Blood (1998) 0.89
Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic model. Antimicrob Agents Chemother (2001) 0.89
Intra-individual variability of caffeine elimination in healthy subjects. Int J Clin Pharmacol Ther Toxicol (1992) 0.88
N-acetyl-p-benzoquinone imine-induced changes in the energy metabolism in hepatocytes. Chem Biol Interact (1990) 0.88
Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol (2010) 0.88
Human visual function in the North Carolina clinical study on possible estuary-associated syndrome. J Toxicol Environ Health A (2001) 0.88
Alternative processing of IgA pre-mRNA responds like IgM to alterations in the efficiency of the competing splice and cleavage-polyadenylation reactions. Mol Immunol (1995) 0.87
Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis (2001) 0.87
A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells. DNA Cell Biol (1995) 0.86
The first year in Columbia: assessments of low hospitalization rate and high office use. Johns Hopkins Med J (1971) 0.86
Appropriate dosing in patients with impaired renal function on medical wards before and after an educational intervention. Int J Clin Pharmacol Ther (2010) 0.85
Absorption of ipsapirone along the human gastrointestinal tract. Br J Clin Pharmacol (1994) 0.85
Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines. Virchows Arch (2000) 0.85
Pyriform augmentation as an ancillary procedure in facial rejuvenation surgery. Plast Reconstr Surg (1999) 0.85
Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood (1998) 0.85
Multiple features contribute to efficient constitutive splicing of an unusually large exon. Nucleic Acids Res (2001) 0.84
Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Ann Oncol (1998) 0.84
Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A. Clin Pharmacol Ther (2000) 0.83
Origin of genes encoding multi-enzymatic proteins in eukaryotes. Trends Genet (1997) 0.83
Decrease of caffeine elimination in man during co-administration of 4-quinolones. J Antimicrob Chemother (1987) 0.83
Intestinal sucrase deficiency. Trans Assoc Am Physicians (1967) 0.82
Interaction between quinolones and caffeine. Drugs (1987) 0.82
Growth suppression of malignant leukemia cell line in vitro by ascorbic acid (vitamin C) and its derivatives. Cancer Lett (1998) 0.82
Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization. Hum Genet (1998) 0.82
Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates. Vaccine (2001) 0.82
Influence of hip orientation on Wingate power output and cycling technique. J Strength Cond Res (2002) 0.82
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a. Int J Clin Pharmacol Ther (2007) 0.81
Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's disease. Clin Pharmacokinet (2001) 0.81
Development of chicken embryos in a pulsed magnetic field. Bioelectromagnetics (1990) 0.81
Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects. Br J Clin Pharmacol (2001) 0.81
[The value of platelet function tests]. Vasa (2003) 0.81
Physiological Nature of Gene-Controlled Growth Form in Trifolium fragiferum L. II. Auxin-Gibberellin Relationships to Growth Form. Plant Physiol (1962) 0.81
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers. J Thromb Haemost (2007) 0.81
Gyrase-inhibitors impair caffeine elimination in man. Methods Find Exp Clin Pharmacol (1987) 0.81
Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine. Eur J Clin Pharmacol (1996) 0.81
When are bioavailability studies required? A German proposal. J Clin Pharmacol (1998) 0.81
Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters. Thromb Res (2000) 0.80
Recommendations for treating adult and geriatric patients on multimedication. Int J Clin Pharmacol Ther (2014) 0.80
A modified T tube for quantitative collection of bile. J Lab Clin Med (1968) 0.80
Experimental rhinovirus infection in human volunteers exposed to ozone. Am Rev Respir Dis (1988) 0.80
Neurobehavioral and sensory irritant effects of controlled exposure to a complex mixture of volatile organic compounds. Neurotoxicol Teratol (1991) 0.80
Cryptic intron activation within the large exon of the mouse polymeric immunoglobulin receptor gene: cryptic splice sites correspond to protein domain boundaries. Nucleic Acids Res (1999) 0.80
Ex vivo porcine vaginal mucosal model of infection for determining effectiveness and toxicity of antiseptics. J Appl Microbiol (2013) 0.80
Inertial effects on mechanically braked Wingate power calculations. Med Sci Sports Exerc (2000) 0.79
Studies of the immunologic defects associated with intestinal lymphangiectasia, with some observations on dietary control of chylous ascites. Ann Intern Med (1968) 0.79
Rats fed high fat diets with increased calcium levels have fecal bile acid concentrations similar to those of rats fed a low fat diet. J Nutr (1994) 0.79
The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa. Mov Disord (2000) 0.79
Effects of antiplatelet agents on platelet-induced thrombin generation. Int J Clin Pharmacol Ther (2002) 0.79
Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol (1996) 0.79
Transcriptional and processing-level control of immunoglobulin gene expression. Ann N Y Acad Sci (1988) 0.79
Absorption behavior of sulpiride described using Weibull functions. Int J Clin Pharmacol Ther (1995) 0.78
Modulation of adhesion molecule expression on endothelial cells by verapamil and other Ca++ channel blockers. Immunobiology (1994) 0.78
Acquisition of virulence-associated factors by the enteric pathogens Escherichia coli and Salmonella enterica. Philos Trans R Soc Lond B Biol Sci (2001) 0.78
Pulmonary function in normal humans with exercise and temperature-humidity stress. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.78
Interaction between the LMWH reviparin and aspirin in healthy volunteers. Br J Clin Pharmacol (2000) 0.78
Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol (1998) 0.78
Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis. Leukemia (2001) 0.78
Juxtamembrane regions in the third intracellular loop of the thyrotropin-releasing hormone receptor type 1 are important for coupling to Gq. Endocrinology (2000) 0.78
The validity of broadly defined hysteria and DSM-III conversion disorder: outcome, family history, and mortality. J Clin Psychiatry (1984) 0.78
Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults. Eur J Med Res (2006) 0.78
Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease. Clin Pharmacol Ther (2001) 0.77
Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A. Int J Clin Pharmacol Ther (2002) 0.77
Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations. Clin Neuropharmacol (1998) 0.77
Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab. Br J Clin Pharmacol (2001) 0.77